US private equity firm York Capital and Cypriot GP Elements Capital Partners have acquired Greek pharma specialist Famar, including its Italian subsidiary Famar Italia.
PE-backed IPOs have been scarce in France in the past five years, according to Unquote Data
GP is acquiring a 51.8% stake in the company, alongside its management, according to Finansavisen
With this sale, Eurazeo reaps a 1.5x return on its initial investment, made in 2017 alongside Goldman Sachs
Priveq exits the company four years after acquiring a 40% stake